ARTICLE | Clinical News

Faster-acting insulin aspart regulatory update

December 14, 2015 8:00 AM UTC

Novo Nordisk submitted an MAA to EMA and an NDA to FDA for faster-acting insulin aspart to treat Type I and II diabetes. The company plans to make the product available in the FlexTouch prefilled deli...